SEPTEMBER 2021LIFE SCIENCES REVIEW 19unique method of combining different drug products, which not only reduced the original side effects but also improved the overall efficacy. However, since he didn't have sufficient clinical evidence to back his claim, he was unable to secure approval from the FDA. That was when he sought the help of Frontage. Within a short period of time, Frontage generated additional evidence-backed data to support his claim, which not only enabled him to get FDA approval, but also secured him an investment of up to 19 million. This is but one of the many instances where Frontage has guided innovators as well as pharma companies in getting their products through the FDA. In addition to these accomplishments, the CRO is also taking active part in mitigating the impact of COVID-19. Frontage's bioanalytical and biologics teams are invested in supporting the development of assay kits designed to detect the COVID-19 virus as well as antibodies and deliver results within 15 minutes. The CRO is also developing and validating a 3-in-1 LC-MS/MS method for the determination of chloroquine, hydroxychloroquine, and azithromycin--three drugs that are under evaluation for treatment of COVID-19.Propelled by such noteworthy contributions, Frontage is witnessing accelerated growth in the pharmaceutical sector. Having already secured its footprint in the U.S., China, and Canada, Frontage is on its way to establishing its presence in Europe and Japan as well. As it grows, the company will also set up new, compliant laboratories aimed at better assisting its clients. "We are committed to ensuring the highest quality and compliance. In months to come, we will assist our growing client base to advance hundreds of molecules through development to commercial launch in global markets," concludes Li. We help innovator, generic, and consumer health companies to file IND, NDA, ANDA, BLA, and 505(b)(2) submissions in global markets, ensuring successful development of important therapies and products for the patients
< Page 9 | Page 11 >